Cardiac Tissue Engineering: Implications for Pediatric Heart Surgery
Open Access
- 25 March 2009
- journal article
- review article
- Published by Springer Nature in Pediatric Cardiology
- Vol. 30 (5) , 716-723
Abstract
Children with severe congenital malformations, such as single-ventricle anomalies, have a daunting prognosis. Heart transplantation would be a therapeutic option but is restricted due to a lack of suitable donor organs and, even in case of successful heart transplantation, lifelong immune suppression would frequently be associated with a number of serious side effects. As an alternative to heart transplantation and classical cardiac reconstructive surgery, tissue-engineered myocardium might become available to augment hypomorphic hearts and/or provide new muscle material for complex myocardial reconstruction. These potential applications of tissue engineered myocardium will, however, impose major challenges to cardiac tissue engineers as well as heart surgeons. This review will provide an overview of available cardiac tissue-engineering technologies, discuss limitations, and speculate on a potential application of tissue-engineered heart muscle in pediatric heart surgery.Keywords
This publication has 62 references indexed in Scilit:
- Accordion-like honeycombs for tissue engineering of cardiac anisotropyNature Materials, 2008
- The Year in Congenital Heart DiseaseJACC, 2008
- Contractile three‐dimensional bioengineered heart muscle for myocardial regenerationJournal of Biomedical Materials Research Part A, 2007
- Engraftment of engineered ES cell–derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardiumJournal of Experimental Medicine, 2006
- Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined FactorsCell, 2006
- Optimizing Engineered Heart Tissue for Therapeutic Applications as Surrogate Heart MuscleCirculation, 2006
- Creation of Engineered Cardiac Tissue In Vitro From Mouse Embryonic Stem CellsCirculation, 2006
- Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarctionNature Medicine, 2006
- Polysurgery of cell sheet grafts overcomes diffusion limits to produce thick, vascularized myocardial tissuesThe FASEB Journal, 2006
- Bone marrow–derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiationNature Medicine, 2004